Rosuvastatin 10mg + Fenofibrate 160mg is a dual-action lipid-lowering formulation designed to effectively manage mixed dyslipidemia and reduce cardiovascular risk. Rosuvastatin belongs to the statin class of medicines that works by inhibiting HMG-CoA reductase, reducing LDL (bad cholesterol), total cholesterol, and triglycerides while increasing HDL (good cholesterol). Fenofibrate is a fibrate that primarily lowers triglycerides and very low-density lipoproteins (VLDL) and improves HDL levels by activating peroxisome proliferator-activated receptors (PPAR-α). This combination therapy is particularly beneficial for patients with: Mixed dyslipidemia High triglycerides High LDL cholesterol Increased cardiovascular risk Metabolic syndrome It provides comprehensive lipid control and helps reduce the risk of heart attack, stroke, and atherosclerosis progression.
